Blood flow and hemodynamics in glaucoma
青光眼的血流和血流动力学
基本信息
- 批准号:10254439
- 负责人:
- 金额:$ 37.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAngiographyAreaAxonBlindnessBlood Pressure MonitorsBlood VesselsBlood capillariesBlood flowCell DeathCellsCharacteristicsChronicClinicalClinical ManagementDiagnosticDiagnostic testsDiseaseDisease ProgressionEyeEye ManifestationsFingersFunctional disorderFutureGlaucomaGoalsImpairmentIndividualLasersMeasurementMeasuresMechanicsMetabolicMethodsNerve DegenerationOptic DiskOptical Coherence TomographyPathogenesisPatientsPhysiologic Intraocular PressurePhysiologic pulsePredispositionPrimary Open Angle GlaucomaProcessRegimenResearchResolutionRetinaRetinal Ganglion CellsRisk FactorsRoleShapesStressStructureSuspect GlaucomasTestingTissuesVasodilationWorkcell injurycohortdensityfunctional losshemodynamicshuman subjectnew technologynovel diagnosticsoptic nerve disorderresponsetemporal measurementtheoriestool
项目摘要
Project Summary / Abstract
Glaucoma is a leading cause of blindness both in the US and worldwide, and is characterized by damage to and
loss of retinal ganglion cells. It is known that blood flow within the optic nerve head and retina are altered in
glaucomatous eyes. Flow may initially increase, but is eventually decreased in eyes with more severe
glaucomatous damage. The capillary density gradually decreases as the disease progresses. There is also
evidence of altered hemodynamics, in that the shape of the pulse waveform measured within the optic nerve
head differs between glaucomatous and healthy eyes. However, it is not yet known whether these changes occur
because axon loss has reduced the metabolic demand; or whether the changes contribute towards retinal
ganglion cell damage and death; or both. This proposal will examine in detail the changes in blood flow and
hemodynamics that occur at different stages of glaucoma. We will leverage new technologies to measure
different aspect of the vasculature, and relate them to disease status and progression, both individually and in
combination. In Aim 1, we will measure blood flow within the optic nerve head and as it passes through the
peripapillary retina, both to quantify the amount of flow and to measure and quantify the pulse waveform. This
will allow us to test whether the observed differences in flow in eyes that are considered glaucoma suspects are
an early part of the disease process that could be measured diagnostically, and/or reflect longstanding
differences that could be used to predict susceptibility to glaucoma. In Aim 2, we will also measure the systemic
pulse waveform in the same individuals. This will allow us to determine whether differences in hemodynamics
that could be measured diagnostically are localized to the eye due to pathophysiologic processes; and/or
represent a systemic risk factor for glaucoma. In Aim 3, we will measure the area of perfused blood vessels, both
in the optic nerve head and the peripapillary retina. This will allow us to determine whether flow is altered within
the remaining vessels after some of the capillaries have been pruned, potentially causing further damage.
Together, these aims will reveal multiple facets of the relation between vascular changes and glaucoma, and
answer major questions that have remained unresolved. Overall, the project will provide substantial advances in
both diagnostic tools and mechanistic understanding of glaucoma.
项目摘要 /摘要
青光眼是美国和世界范围内失明的主要原因,其特征是对
视网膜神经节细胞的丧失。众所周知,视神经头和视网膜内的血流已改变
青光眼的眼睛。流量最初可能会增加,但最终会减少眼睛,更严重
青光眼损害。随着疾病的发展,毛细管密度逐渐降低。也有
血液动力学改变的证据,是在视神经内测得的脉冲波形的形状
头部的眼睛和健康的眼睛之间有所不同。但是,尚不清楚这些变化是否发生
因为轴突损失减少了代谢需求;或变化是否有助于视网膜
神经节细胞损害和死亡;或两者兼而有之。该建议将详细检查血流的变化和
血液动力学发生在青光眼的不同阶段。我们将利用新技术来衡量
脉管系统的不同方面,并将其与疾病状况和进展相关联
组合。在AIM 1中,我们将测量视神经头内的血流,并通过
乳腺围骨视网膜,既可以量化流量量又测量和量化脉冲波形。这
将使我们能够测试观察到的眼睛流动差异是否被认为是青光眼嫌疑犯的
疾病过程的早期部分,可以诊断为诊断和/或反映长期存在
可用于预测青光眼易感性的差异。在AIM 2中,我们还将测量系统性
同一个人中的脉冲波形。这将使我们能够确定血液动力学的差异
由于病理生理过程,可以通过诊断进行诊断的诊断测量。和/或
代表青光眼的系统性危险因素。在AIM 3中,我们将测量灌注血管的面积
在视神经头和围乳围乳围骨视网膜中。这将使我们能够确定流量是否在内部发生变化
一些毛细血管后的剩余血管进行了修剪,可能会造成进一步的损坏。
总之,这些目标将揭示血管变化与青光眼和青光眼之间的关系的多个方面
回答尚未解决的主要问题。总体而言,该项目将在
诊断工具和对青光眼的机械理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stuart Gardiner其他文献
Stuart Gardiner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stuart Gardiner', 18)}}的其他基金
Functional Testing and Quality of Life in Glaucoma
青光眼的功能测试和生活质量
- 批准号:
10734431 - 财政年份:2023
- 资助金额:
$ 37.82万 - 项目类别:
相似国自然基金
冠状小微血管超声微泡造影多灌注峰参量三维高时空分辨成像
- 批准号:12374444
- 批准年份:2023
- 资助金额:53 万元
- 项目类别:面上项目
针对活体微血管成像的时空融合运动衬度X射线造影术
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于超声造影血流灌注智能定量系统明确血管正常化“窗口期”提升肺癌免疫检查点抑制剂疗效的研究
- 批准号:82272007
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
超声造影评价SOCS3通过miRNAs靶向介导的自噬途径调控血管新生对缺血性脑卒中的作用研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
超声造影评价SOCS3通过miRNAs靶向介导的自噬途径调控血管新生对缺血性脑卒中的作用研究
- 批准号:82202158
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
High-Resolution Flow Imaging of Optic Nerve Head and Retrolaminar Microvascular Circulation
视神经乳头和层后微血管循环的高分辨率血流成像
- 批准号:
10649225 - 财政年份:2023
- 资助金额:
$ 37.82万 - 项目类别:
Learning-based 3D modeling of AMD to assess disease progression and response to treatment
基于学习的 AMD 3D 建模,用于评估疾病进展和治疗反应
- 批准号:
10592517 - 财政年份:2023
- 资助金额:
$ 37.82万 - 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
- 批准号:
10635325 - 财政年份:2023
- 资助金额:
$ 37.82万 - 项目类别:
MMP-9 based immune-driven mechanisms of neovascular AMD
基于MMP-9的新生血管性AMD的免疫驱动机制
- 批准号:
10719958 - 财政年份:2023
- 资助金额:
$ 37.82万 - 项目类别:
Novel ultrahigh speed swept source OCT angiography methods in diabetic retinopathy
糖尿病视网膜病变的新型超高速扫源 OCT 血管造影方法
- 批准号:
10656644 - 财政年份:2023
- 资助金额:
$ 37.82万 - 项目类别: